ZA200705159B - Heterocyclic compounds as CCR2B antagonists - Google Patents

Heterocyclic compounds as CCR2B antagonists

Info

Publication number
ZA200705159B
ZA200705159B ZA200705159A ZA200705159A ZA200705159B ZA 200705159 B ZA200705159 B ZA 200705159B ZA 200705159 A ZA200705159 A ZA 200705159A ZA 200705159 A ZA200705159 A ZA 200705159A ZA 200705159 B ZA200705159 B ZA 200705159B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
ccr2b
antagonists
ccr2b antagonists
heterocyclic
Prior art date
Application number
ZA200705159A
Other languages
English (en)
Inventor
Bower Justin Fairfield
Turner Paul
Winter Jon
Poyser Jeffrey Philip
Waterson David
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200705159B publication Critical patent/ZA200705159B/xx

Links

ZA200705159A 2004-12-24 2007-06-22 Heterocyclic compounds as CCR2B antagonists ZA200705159B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0428327A GB0428327D0 (en) 2004-12-24 2004-12-24 Method

Publications (1)

Publication Number Publication Date
ZA200705159B true ZA200705159B (en) 2008-06-25

Family

ID=34130900

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705159A ZA200705159B (en) 2004-12-24 2007-06-22 Heterocyclic compounds as CCR2B antagonists

Country Status (4)

Country Link
CN (1) CN101128427B (zh)
GB (1) GB0428327D0 (zh)
UA (1) UA93489C2 (zh)
ZA (1) ZA200705159B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
AU2020343737A1 (en) * 2019-09-05 2022-03-31 Lunan Pharmaceutical Group Corporation MAGL inhibitor, preparation method therefor and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000342A1 (en) * 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
WO2002038547A1 (en) * 2000-11-13 2002-05-16 Glaxosmithkline Spa Quinoline derivatives as nk-3 and nk-2 antagonists
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002079151A1 (en) * 2001-03-29 2002-10-10 Smithkline Beecham P.L.C. 3-substituted indoels or fused pyrroles as antagonists of the chemokine mcp-1 (ccr2b) receptor
US7491737B2 (en) * 2002-10-30 2009-02-17 Merck & Co., Inc. Heterarylpiperidine modulators of chemokine receptor activity
FR2872813B1 (fr) * 2004-07-09 2007-01-19 Sanofi Synthelabo Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CN101128427B (zh) 2013-03-27
CN101128427A (zh) 2008-02-20
UA93489C2 (ru) 2011-02-25
GB0428327D0 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
IL183665A0 (en) Heterocyclic compounds as ccr2b antagonists
IL180587A0 (en) Heterocyclic compounds
SI1919907T1 (sl) Heterocikliäśna spojina
ZA200709051B (en) Heterocyclic compound
IL179414A0 (en) Fused heterocyclic compound
EP1880993A4 (en) NITROGENIC HETEROCYCLIC COMPOUND
IL222922A0 (en) Neuropilin antagonists
HK1123038A1 (en) Heterocyclic compounds
TWI370820B (en) Fused heterocyclic compounds
IL181219A0 (en) Heterocyclic antiviral compounds
IL179534A0 (en) Heterocyclic antiviral compounds
ZA200705670B (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
IL182828A0 (en) Constrained compounds as cgrp-receptor antagonists
GB0404124D0 (en) Antagonists of GIP
EP1940412A4 (en) NEW OPIOID ANTAGONISTS
IL183647A (en) The heterocyclic compounds are converted into 3-ethylidenehydrazino
IL185326A0 (en) PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
EP1737446A4 (en) CONDENSED HETEROCYCLIC COMPOUNDS
EP1776112A4 (en) HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
ZA200702380B (en) Substituted heterocyclic compounds and uses thereof
IL195158A0 (en) Novel heterocyclic compounds
EP1760079A4 (en) COMPOUNDS AS CCR5 ANTAGONISTS
EP1799653A4 (en) NEW HETEROCYCLES
ZA200700162B (en) Novel heterocyclic compounds
EP2039695A4 (en) BICYCLIC HETEROCYLIC COMPOUND AND ITS USE